Royalty Pharma (RPRXN) Ownership - Who Owns Royalty Pharma?
Royalty Pharma (RPRXN) Ownership Overview
- 1.46% Insiders
- 21.41% Mutual Funds
- 5.09% Other Institutional Investors
- 11.84% ETFs
- 60.20% Public Companies and Individual Investors
The ownership structure of Royalty Pharma (MX:RPRXN) stock is a mix of institutional, retail, and individual investors. Approximately 38.34% of the company’s stock is owned by Institutional Investors, 1.46% is owned by Insiders, and 60.20% is owned by Public Companies and Individual Investors.
The ownership structure of Royalty Pharma (MX:RPRXN) stock is a mix of institutional, retail, and individual investors. Approximately 38.34% of the company’s stock is owned by Institutional Investors, 1.46% is owned by Insiders, and 60.20% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 27,832,977 | Institution | 6.23% | 1,817,771,728 |
| New Perspective Fund | 19,645,749 | Institution | 4.40% | 1,283,063,867 |
| Ishares | 16,061,781 | Institution | 3.60% | 1,048,994,917 |
| Vanguard | 8,891,667 | Institution | 1.99% | 580,714,772 |
| Growth Fund Of America | 7,986,638 | Institution | 1.79% | 521,607,328 |
| Capital Income Builder | 7,427,586 | Institution | 1.66% | 485,095,642 |
| Morgan Stanley Institutional Fund Inc | 5,418,075 | Institution | 1.21% | 353,854,478 |
| Fidelity Concord Street Trust | 5,252,818 | Institution | 1.18% | 343,061,544 |
| Pablo G. Legorreta | 4,912,195 | Insider | 1.10% | 320,815,455 |
| Vanguard Index Funds | 4,471,210 | Institution | 1.00% | 292,014,725 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| New Perspective Fund | 19,645,749 | Institution | 4.40% | 1,283,063,867 |
| Growth Fund Of America | 7,986,638 | Institution | 1.79% | 521,607,328 |
| Capital Income Builder | 7,427,586 | Institution | 1.66% | 485,095,642 |
| Morgan Stanley Institutional Fund Inc | 5,418,075 | Institution | 1.21% | 353,854,478 |
| Fidelity Concord Street Trust | 5,252,818 | Institution | 1.18% | 343,061,544 |
| Vanguard Index Funds | 4,471,210 | Institution | 1.00% | 292,014,725 |
| T. Rowe Price Value Fund, Inc. | 3,124,945 | Institution | 0.70% | 204,090,158 |
| Fidelity Salem Street Trust | 2,810,085 | Institution | 0.63% | 183,526,651 |
| Fidelity Securities Fund | 2,710,400 | Institution | 0.61% | 177,016,224 |
| Transamerica Funds | 2,404,531 | Institution | 0.54% | 157,039,920 |
FAQ
Who Owns Royalty Pharma (MX:RPRXN)?
According to the latest TipRanks data, approximately 38.34% of the company's stock is held by institutional investors, 1.46% is held by insiders, and 60.20% is held by public companies and individual investors.
What percentage of Royalty Pharma (MX:RPRXN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.34% of Royalty Pharma (MX:RPRXN) stock is held by institutional investors: 21.41% by mutual funds, 11.84% by ETFs and 5.09% by other institutional investors.
What percentage of Royalty Pharma (MX:RPRXN) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.20% of Royalty Pharma (MX:RPRXN) stock is held by public companies and individual investors.
Who owns the most shares of Royalty Pharma (MX:RPRXN)?
BlackRock, Inc. owns the most shares of Royalty Pharma (MX:RPRXN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
